Fact CheckerSign in

NCT06108102Enrolling by invitation

International Post-Stroke Epilepsy Research Repository

International Post Stroke Epilepsy Research Repository to Characterize Post-stroke Epilepsy Population and Their Outcomes

Source: ClinicalTrials.gov · Last updated 29 Oct 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The International Post-Stroke Epilepsy Research Repository (IPSERR): The study aims to collate and categorize data reported by post-stroke epilepsy (PSE) researchers and lodge it within the IPSERR. Using the IPSERR database, we will conduct two individual patient data (IPD) analyses: (1) determine epilepsy, functional, and cognitive outcomes in stroke patients who develop post-stroke seizure and (2) build and validate post-stroke epilepsy prediction model and compare performance against existing models.

Status (registry)
Enrolling by invitation
Study type
Observational
Enrollment
8000 (estimated)
First submitted
24 Oct 2023
Start date
1 Mar 2024
Primary completion date
Dec 2029
Lead sponsor
Yale University
Diseases
Epilepsy, Stroke
NCT number
NCT06108102

What you commit to

  • Study type: Observational
  • Planned participants: 8000
  • From 1 Mar 2024 to the primary completion date, Dec 2029
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Studies of patients with a prior history of seizures before the index stroke,

Other

  • Studies that did not report outcome data, or are not able to share IPD.

Who the study is looking for

  • Studies with minimum dataset of 100 patients
  • Studies comprising stroke patients aged ≥18 years, with ischemic or hemorrhagic stroke, presenting early or late PSS with data on patient outcome measures.
  • Documented consent or waiver of consent following local Institutional Review Board-approved procedure.
  • Studies published on human subjects.
  • No restriction based on the date or language of publication, gender, or ethnicity.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Yale University
Coordinator of this site? Confirm its status
New HavenUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.